BioSenic S.A. (EBR:BIOS)
Belgium · Delayed Price · Currency is EUR 0.0020
0.00 (0.00%)
At close: Oct 9, 2026
BioSenic Market Cap
BioSenic has a market cap or net worth of €1.31 million as of October 9, 2026. It is the 48,731st most valuable company in the world and the 114th biggest in Belgium. Its market cap has decreased by 16.67% in one year.
Market Cap
1.31M
Enterprise Value
24.33M
Revenue
-2.39M
Global Rank
Country Rank
#114 Belgium
PE Ratio
n/a
ChartMarket Cap Chart
Since October 26, 2022, BioSenic's market cap has decreased from 7.09M to 1.31M, a decrease of -81.59%. That is a compound annual growth rate of -34.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.31M | -13.04% |
| Dec 31, 2025 | 1.50M | -20.08% |
| Dec 31, 2024 | 1.88M | -81.19% |
| Dec 29, 2023 | 9.99M | 233.11% |
| Dec 30, 2022 | 3.00M | -57.74% |
| Oct 26, 2022 | 7.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 44.13B |
| UCB SA | 38.48B |
| Financière de Tubize | 7.54B |
| Onward Medical | 170.69M |
| Hyloris Pharmaceuticals | 110.60M |
| European Medical Solutions | 15.32M |
| Celyad Oncology | 10.30M |
| Oxurion NV | 168.88K |